6476 - 6500 of 9034 Results
Title
Year
- Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart Review2018RESTRICTEDTitle: Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart ReviewJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 41Issue #: 5Start Page: 156End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000296Citation Count: 12
- Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson Disease2010RESTRICTEDTitle: Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson DiseaseJournal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 67Issue #: 5Start Page: 1377End Page: 1385Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1227/neu.0b013e3181f53a5cCitation Count: 71
-
OPENTitle: Beliefs About Use of Complementary Health Approaches for Parkinson's DiseaseJournal Name: Holistic Nursing PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 31Issue #: 5Start Page: 290End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/hnp.0000000000000229Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5664950Citation Count: 0
-
OPENTitle: Paraquat Neurotoxicity is Distinct from that of MPTP and RotenoneJournal Name: Toxicological SciencesPublisher: Oxford University Press (OUP)Vol: 88Issue #: 1Start Page: 193End Page: 201Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/toxsci/kfi304Best OA location URL: https://academic.oup.com/toxsci/article-pdf/88/1/193/4676394/kfi304.pdfCitation Count: 269
-
OPENTitle: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 1SStart Page: S62End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011Best OA location URL: http://doi.org/10.1016/j.jalz.2013.12.011Citation Count: 70
-
OPENTitle: fMRI-based deep brain stimulation programming for Parkinson's disease: a blinded, crossover clinical trialJournal Name: Brain StimulationPublisher: Elsevier BVVol: 19Issue #: 2Start Page: 103069End Page: 103069Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2026.103069Best OA location URL: https://www.brainstimjrnl.com/article/S1935-861X(26)00046-X/pdfCitation Count: 1
-
OPENTitle: Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 672End Page: 680Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28382Best OA location URL: https://doi.org/10.1002/mds.28382Citation Count: 23
-
OPENTitle: Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson’s DiseaseJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page: 23814683211021380End Page: 23814683211021380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/23814683211021380Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/23814683211021380Citation Count: 14
-
OPENTitle: Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) DimerizationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 11Start Page: 1971End Page: 1980Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00259Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.3c00259Citation Count: 24
-
OPENTitle: Mitochondrial therapies for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page: S155End Page: 60Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22781Best OA location URL: http://doi.org/10.1002/mds.22781Citation Count: 62
- Dysphagia Is Associated with Incident Non‐Motor Symptoms in Parkinson's Disease2025RESTRICTEDTitle: Dysphagia Is Associated with Incident Non‐Motor Symptoms in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 12Issue #: 11Start Page: 1909End Page: 1924Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.70297Citation Count: 0
-
OPENTitle: PINK 1 autophosphorylation is required for ubiquitin recognitionJournal Name: The EMBO ReportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embr.201744981Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embr.201744981Citation Count: 117
- Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulation2018RESTRICTEDTitle: Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulationJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 390Issue #:Start Page: 33End Page: 35Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2018.04.002Citation Count: 2
- What Parkinson's disease patients say in their own words about their mood and anxiety symptoms2024RESTRICTEDTitle: What Parkinson's disease patients say in their own words about their mood and anxiety symptomsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 130Issue #:Start Page: 107190End Page: 107190Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107190Citation Count: 3
-
OPENTitle: Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trialJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 69Issue #:Start Page: 102474End Page: 102474Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.eclinm.2024.102474Best OA location URL: http://www.thelancet.com/article/S2589537024000531/pdfCitation Count: 26
-
OPENTitle: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLBJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 115Issue #: 51Start Page: E12053End Page: E12062Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1813365115Best OA location URL: https://www.pnas.org/content/pnas/115/51/E12053.full.pdfCitation Count: 92
-
OPENTitle: Minimal Clinically Important Difference for UPDRS‐III in Daily PracticeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 4Start Page: 448End Page: 450Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12632Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12632Citation Count: 63
-
OPENTitle: Dual role of USP 30 in controlling basal pexophagy and mitophagyJournal Name: The EMBO ReportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embr.201745595Best OA location URL: https://doi.org/10.15252/embr.201745595Citation Count: 163
- Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's Disease2020RESTRICTEDTitle: Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 178End Page: 187Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28299Citation Count: 49
- Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia2013RESTRICTEDTitle: Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesiaJournal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 77Issue #: 4Start Page: 242End Page: 246Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neures.2013.10.002Citation Count: 47
-
OPENTitle: Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1632End Page: 1642Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27404Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27404Citation Count: 16
-
OPENTitle: Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 120Issue #:Start Page: 107End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.004Best OA location URL: https://doaj.org/article/2232316968e3403b8d7208ad3725eaf1Citation Count: 148
-
OPENTitle: Stimulation-induced reversed plus-minus syndrome: Insights into eyelid physiologyJournal Name: Brain StimulationPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 951End Page: 952Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2018.04.010Best OA location URL: https://doaj.org/article/b711f7d9567240b89145b894bc21f1beCitation Count: 3
- Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasia2016OPENTitle: Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasiaJournal Name: CortexPublisher: Elsevier BVVol: 83Issue #:Start Page: 124End Page: 135Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cortex.2016.07.004Best OA location URL: https://doi.org/10.1016/j.cortex.2016.07.004Citation Count: 23
-
OPENTitle: Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson’s disease patients with defined cholinergic lossesJournal Name: NeuroImagePublisher: Elsevier BVVol: 149Issue #:Start Page: 295End Page: 304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.02.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5386784Citation Count: 50